Brought to you by 
Biocompatibles International licenses BioCure's microspheres
11 Sep 2020
Executive Summary
Biotech company BioCure licensed UK firm Biocompatibles International (medical devices) exclusive worldwide manufacturing, marketing, and distribution rights to its PVA-based microspheres embolic product to treat benign fibroid tumors.
Deal Industry
- Biotechnology
- Medical Devices
-
Pharmaceuticals
- Drug Delivery
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- Intra-Biotech Deal
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Biocompatibles International licenses BioCure's microspheres
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice